Thryv Therapeutics | Biotech & Life Sciences

01Company Overview

Thryv Therapeutics Inc. is a clinical-stage biotech pioneering precision medicine approaches to treating genetic arrhythmia syndromes and acquired cardiometabolic diseases through potent and highly selective inhibitors of serum glucocorticoid inducible kinase 1 (SGK1).

02Backed By1 investor

LVLumira Ventures→

03Similar Companies